ENTERA BIO LTD. Other Current Assets
ENTERA BIO LTD. (ENTX) had Other Current Assets of $144.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-07
- 2026-06-30: Other Assets, Current $144.00K.
- 2026-03-31: Other Assets, Current $256.00K.
- 2025-12-31: Other Assets, Current $107.00K; Other Assets, Current as first filed $415.00K.
- 2025-09-30: Other Assets, Current $262.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $144.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $256.00K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $107.00K 10-Q · filed 2026-08-07 | $415.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $262.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $192.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $165.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $186.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $89.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $67.00K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $39.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $238.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $263.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $354.00K 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $653.00K 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $294.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | $634.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $922.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.32M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $254.00K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $261.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |